Commonwealth Equity Services
HELX icon

Commonwealth Equity Services’s Franklin Genomic Advancements ETF HELX Stock Holding History

Commonwealth Equity Services’s Portfolio HELX Stock Details HELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,677
Closed -$212K – 4126
2024
Q2 		$212K Sell
6,677
-365
-5% -$11.4K ﹤0.01% 3592
2024
Q1 		$231K Hold
7,042
– – ﹤0.01% 3506
2023
Q4 		$215K Sell
7,042
-915
-11% -$25.4K ﹤0.01% 3450
2023
Q3 		$225K Buy
7,957
+38
+0.5% +$1.15K ﹤0.01% 3282
2023
Q2 		$239K Sell
7,919
-792
-9% -$24K ﹤0.01% 3235
2023
Q1 		$264 Sell
8,711
-324
-4% -$9.96K ﹤0.01% 3074
2022
Q4 		$272K Buy
9,035
+188
+2% +$5.78K ﹤0.01% 2951
2022
Q3 		$262K Buy
8,847
+372
+4% +$12.3K ﹤0.01% 2934
2022
Q2 		$271K Sell
8,475
-2,143
-20% -$70.7K ﹤0.01% 2931
2022
Q1 		$392K Sell
10,618
-4,382
-29% -$167K ﹤0.01% 2733
2021
Q4 		$727K Sell
15,000
-131
-0.9% -$6.53K ﹤0.01% 2224
2021
Q3 		$791K Sell
15,131
-1,191
-7% -$64.4K ﹤0.01% 2109
2021
Q2 		$845K Sell
16,322
-55
-0.3% -$2.46K ﹤0.01% 2048
2021
Q1 		$710K Buy
16,377
+10,279
+169% +$481K ﹤0.01% 2062
2020
Q4 		$270K Buy
6,098
+178
+3% +$7.09K ﹤0.01% 2665
2020
Q3 		$207K Buy
+5,920
New +$202K ﹤0.01% 2689

Other funds holding HELX

GT
Glenview Trust Louisville, Kentucky $6.37B AUM 23.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services's HELX Position: Q3 2024 in Review

Commonwealth Equity Services sold out of Franklin Genomic Advancements ETF (HELX) in Q3 2024, closing a stake of 6,677 shares — an estimated $212K sold.

Commonwealth Equity Services first reported a position in HELX in Q3 2020 and held it in 16 quarters. The position peaked at $845K in Q2 2021. 5 funds tracked by Wall St. Rank hold HELX as of Q3 2024.

  • Commonwealth Equity Services reported no remaining Franklin Genomic Advancements ETF position as of Q3 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 6,677 Franklin Genomic Advancements ETF shares in Q3 2024, an estimated $212K.
  • Commonwealth Equity Services first reported a position in Franklin Genomic Advancements ETF in Q3 2020 and held it in 16 quarters.
  • Commonwealth Equity Services's Franklin Genomic Advancements ETF position peaked at $845K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q3 2024.

Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.